vs
Side-by-side financial comparison of Instil Bio, Inc. (TIL) and TMC the metals Co Inc. (TMC). Click either name above to swap in a different company.
Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.3M, roughly 1.7× TMC the metals Co Inc.). Instil Bio, Inc. runs the higher net margin — -365.3% vs -3136.5%, a 2771.1% gap on every dollar of revenue. On growth, TMC the metals Co Inc. posted the faster year-over-year revenue change (2425.5% vs -19.2%).
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
The Metals Company, formerly DeepGreen Metals, is a Canadian deep sea mining exploration company. The company focuses on the mining of polymetallic nodules in the Clarion Clipperton Zone of the Pacific.
TIL vs TMC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2M | $1.3M |
| Net Profit | $-8.2M | $-40.4M |
| Gross Margin | — | — |
| Operating Margin | -426.3% | -3470.9% |
| Net Margin | -365.3% | -3136.5% |
| Revenue YoY | -19.2% | 2425.5% |
| Net Profit YoY | 31.1% | -151.5% |
| EPS (diluted) | $-1.13 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2M | $1.3M | ||
| Q3 25 | $2.2M | $1.3M | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $2.2M | — | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
| Q4 25 | $-8.2M | $-40.4M | ||
| Q3 25 | $-13.6M | $-184.5M | ||
| Q2 25 | $-21.4M | — | ||
| Q1 25 | $-28.2M | — | ||
| Q4 24 | $-11.9M | — | ||
| Q3 24 | $-23.0M | — | ||
| Q2 24 | $-14.9M | — | ||
| Q1 24 | $-24.3M | — |
| Q4 25 | -426.3% | -3470.9% | ||
| Q3 25 | -670.0% | -4134.4% | ||
| Q2 25 | -1045.5% | — | ||
| Q1 25 | -1363.2% | — | ||
| Q4 24 | -426.1% | — | ||
| Q3 24 | -1582.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -365.3% | -3136.5% | ||
| Q3 25 | -606.0% | -13780.2% | ||
| Q2 25 | -954.2% | — | ||
| Q1 25 | -1257.8% | — | ||
| Q4 24 | -428.8% | — | ||
| Q3 24 | -1541.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-1.13 | $0.11 | ||
| Q3 25 | $-2.01 | $0.46 | ||
| Q2 25 | $-3.24 | — | ||
| Q1 25 | $-4.32 | — | ||
| Q4 24 | $-1.82 | — | ||
| Q3 24 | $-3.54 | — | ||
| Q2 24 | $-2.29 | — | ||
| Q1 24 | $-3.74 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.6M | $117.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $113.9M | $-33.4M |
| Total Assets | $203.5M | $181.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.6M | $117.6M | ||
| Q3 25 | $5.8M | $115.6M | ||
| Q2 25 | $7.7M | — | ||
| Q1 25 | $15.4M | — | ||
| Q4 24 | $8.8M | — | ||
| Q3 24 | $6.7M | — | ||
| Q2 24 | $6.8M | — | ||
| Q1 24 | $5.5M | — |
| Q4 25 | $113.9M | $-33.4M | ||
| Q3 25 | $120.4M | $-40.6M | ||
| Q2 25 | $131.7M | — | ||
| Q1 25 | $144.9M | — | ||
| Q4 24 | $169.4M | — | ||
| Q3 24 | $176.3M | — | ||
| Q2 24 | $195.0M | — | ||
| Q1 24 | $205.8M | — |
| Q4 25 | $203.5M | $181.6M | ||
| Q3 25 | $211.8M | $175.6M | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $237.4M | — | ||
| Q4 24 | $263.6M | — | ||
| Q3 24 | $272.6M | — | ||
| Q2 24 | $294.3M | — | ||
| Q1 24 | $306.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.1M | $-11.4M |
| Free Cash FlowOCF − Capex | — | $-11.5M |
| FCF MarginFCF / Revenue | — | -889.8% |
| Capex IntensityCapex / Revenue | — | 8.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.1M | $-11.4M | ||
| Q3 25 | $-10.6M | $-11.5M | ||
| Q2 25 | $-14.8M | — | ||
| Q1 25 | $-4.2M | — | ||
| Q4 24 | $-10.6M | — | ||
| Q3 24 | $-20.1M | — | ||
| Q2 24 | $-10.6M | — | ||
| Q1 24 | $-14.4M | — |
| Q4 25 | — | $-11.5M | ||
| Q3 25 | — | $-11.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -889.8% | ||
| Q3 25 | — | -859.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
